top of page
  • Dr. J. James Frost

Oncology Imaging

Updated: May 10

Cancer imaging has been a focal point of Dr. Frost and BioMolecular Imaging in the clinic and in research for decades. This extends from standard nuclear medicine imaging to the first FDG PET implementation at Johns Hopkins and has also led to novel investigatory work that first demonstrated elevated mu and delta opiate receptors in lung carcinoma patients.



As with other organ systems, Dr. Frost and BioMolecular Imaging are able to assist you in developing any complex strategy involving oncologic imaging.

Elevated delta opiate receptors in lung carcinoma, T, compared to heart (H) and contralateral lung (L) https://jnm.snmjournals.org/content/48/2/207.short

FDG PET in the same individual (T). https://jnm.snmjournals.org/content/48/2/207.short

Dr. Frost has also published an article trilogy dealing with cancer physics, information, and computation. These lay out the fundamental and foundational properties of cancer, including symmetry breaking and computational intelligence.


For additional information on these topics please see https://www.drjjamesfrost.com.


In the area of commercial development, Dr. Frost has been an active presence for many pharmaceutical industry partners; first-time biotech companies embarking on molecular imaging ventures; bringing new molecular imaging probes to FDA approval; and helping launch new agents by chairing company advisory boards and educating the clinic physicians.


He is also a board-certified radiologist and nuclear medicine physician and has a PhD in nuclear and radiochemistry. Accordingly, he is capable of achieving the first high-level evaluation for any new project and then helping develop the in-depth components that immediately follow. When subdomain expertise is needed, Dr. Frost can draw on a long list of specialists in radiochemistry, physics, imaging CROs, and others and bring them to the table.


About BioMolecular Imaging


BioMolecular Imaging (BMI Consultants) is a molecular imaging and clinical trial consultancy owned and operated by Dr. J. James Frost M.D./Ph.D out of Baltimore Maryland. BMI has been involved with clinical, therapeutic & diagnostic imaging focused on Oncology, Brain, Biomarkers, Cardiology and Central Image Interpretations for over 20 years.


To learn more about BioMolecular Imaging, please visit https://www.BioMolecularImaging.com or connect with:



Copyright © 2023 BioMolecular Imaging


BioMolecular Imaging is a registered trademark of BioMolecular Imaging D.B.A. BMI Consultants

137 views0 comments

Recent Posts

See All

Comments


bottom of page